Dual Checkpoint Inhibition Shows Promise in Molecularly Selected Prostate Cancer Patients
Phase II trial reveals promising results for dual immune checkpoint inhibition in specific mCRPC patients.
Small Cell Lung Cancer
1 article
Antibiotics, PPIs, and Probiotics: No Impact on Immunotherapy Outcomes in ES-SCLC
Study finds common medications don't affect immunotherapy efficacy in extensive-stage small cell lung cancer.